We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DERIVATIVES OF RECOMBINANT PROTEINS, HOMO-MULTIMERS OF GRANULOCYTE COLONY-STIMULATING FACTOR AND METHOD OF PREPARATION THEREOF
NEW PHOTOCHROMIC COMPOUNDS, METHOD OF PRODUCTION THEREOF AND INTERMEDIATE COMPOUNDS
METHOD AND SYSTEM OF ALGAL CELLS DISRUPTION AND ISOLATION OF BIOPRODUCTS THEREFROM
PROCESS FOR PREPARATION AND PURIFICATION OF RECOMBINANT HUMAN ONCOSTATIN M PROTEIN
SPIRO[CHROMAN-2,2'-INDOLE]DERIVATIVES AS CYANIDE ION CHEMOSENSORS
FUSED PROTEINS OF GRANULOCYTE COLONY-STIMULATING FACTOR WITH OTHER PARTNERS OF GROWTH FACTOR, PREFERABLY WITH STEM CELL FACTOR, AND METHOD OF PREPARATION THEREOF
FUSED PROTEINS OF INTERFERON ALPHA 5 WITH ANOTHER CYTOKINE AND A PROCESS FOR PRODUCING THEREOF
MODIFIED STARCH FLOCCULANT AND METHOD OF PRODUCING THEREOF